| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $18K | +0.0% | +0.0% |
| Cost of Revenue | $21K | +1317.9% | +1317.9% |
| Gross Profit | -$3K | -116.1% | -116.1% |
| R&D Expense | $544K | -24.2% | +5.0% |
| Operating Income | -$1.2M | +7.8% | -14.0% |
| Pre-tax Income | -$1.1M | +7.8% | -19.6% |
| Net Income | -$1.1M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $3.9M | -9.6% | -19.4% |
| Short-term Investments | $1.9M | +1.2% | -38.2% |
| Current Assets | $6.2M | -3.3% | -25.4% |
| Total Assets | $6.4M | -4.0% | -25.5% |
| Current Liabilities | $708K | -32.5% | -32.2% |
| Total Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.9M | — | — |
| Investing Cash Flow | $1.2M | — | — |
| Financing Cash Flow | $2.7M | — | — |
| +7.8% |
| -19.6% |
| EPS (Basic) | -$0.12 | +36.8% | +45.5% |
| EPS (Diluted) | -$0.12 | +36.8% | +45.5% |
| $1.4M |
| -20.7% |
| -22.9% |
| Stockholders' Equity | $5.0M | +1.9% | -26.1% |